OCUL
OCUL
NASDAQ · Pharmaceuticals

Ocular Therapeutix Inc

$8.18
-0.09 (-1.09%)
As of Mar 22, 10:04 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +593.2% upside
Low Target $44.23
Average Target $56.70
High Target $95.28
Current Price $8.18
Current
$8.18
Target
$56.70
$44.23 $56.70 avg $95.28
Scenario Analysis
Bear Case
$44.23
440.7%
Low target
Base Case
$56.70
+593.2%
Avg target
Bull Case
$95.28
+1,064.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$16.44
-50.2% from high
52-Week Low
$5.80
+41.0% from low
Target vs 52W High
$56.70
+244.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%